Not withstanding the seemingly insurmountable regulatory hurdles, I think 6 and 1/2 months after CE Mark and EuGeni launch you're entitled to have reasonable expectations of revenue starting to flow.
More revenue came in, $214,000 in the June quarter than the $135,000 this quarter.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-55
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $59.24M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 903236 | 6 |
View Market Depth
| Last trade - 07.45am 13/09/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable